Edition:
United Kingdom

Aethlon Medical Inc (AEMD.OQ)

AEMD.OQ on NASDAQ Stock Exchange Capital Market

1.36USD
21 May 2018
Change (% chg)

$0.03 (+2.26%)
Prev Close
$1.33
Open
$1.36
Day's High
$1.36
Day's Low
$1.33
Volume
26,179
Avg. Vol
42,227
52-wk High
$3.85
52-wk Low
$0.80

Chart for

About

Aethlon Medical, Inc. is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The Company's... (more)

Overall

Beta: 2.18
Market Cap(Mil.): $21.13
Shares Outstanding(Mil.): 16.70
Dividend: --
Yield (%): --

Financials

  AEMD.OQ Industry Sector
P/E (TTM): -- 39.22 32.53
EPS (TTM): -0.65 -- --
ROI: -202.33 14.34 12.63
ROE: -253.42 17.22 14.50

BRIEF-Aethlon Medical Participates In Informational Meeting With FDA​

* AETHLON MEDICAL SAYS ‍ON MARCH 20, CO PARTICIPATED IN AN INFORMATIONAL MEETING WITH FDA​ - SEC FILING

21 Mar 2018

BRIEF-Aethlon Medical Announces Fiscal 2018 Third Quarter Results

* AETHLON MEDICAL ANNOUNCES FISCAL 2018 THIRD QUARTER RESULTS

01 Feb 2018

BRIEF-Aethlon Medical Says Granted U.S. Patent That Broadens Protection For The Aethlon Hemopurifier

* AETHLON MEDICAL ANNOUNCES ALLOWANCE OF U.S. PATENT THAT BROADENS PROTECTION FOR THE AETHLON HEMOPURIFIER® TO TREAT VIRAL INFECTIONS Source text for Eikon: Further company coverage:

18 Jan 2018

BRIEF-Sabrina Johnson Joins Aethlon Medical's Board Of Directors

* SABRINA MARTUCCI JOHNSON JOINS AETHLON MEDICAL'S BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

10 Jan 2018

BRIEF-Aethlon Medical Names Dr. Charles J. Fisher Chairman Of The Board

* AETHLON MEDICAL NAMES DR. CHARLES J. FISHER CHAIRMAN OF THE BOARD Source text for Eikon: Further company coverage:

29 Nov 2017

Earnings vs. Estimates